diff --git a/domains/ai-alignment/eu-gpai-requirements-create-extraterritorial-governance-asymmetry-for-us-frontier-labs.md b/domains/ai-alignment/eu-gpai-requirements-create-extraterritorial-governance-asymmetry-for-us-frontier-labs.md index 2dd2781d7..f52f3a55f 100644 --- a/domains/ai-alignment/eu-gpai-requirements-create-extraterritorial-governance-asymmetry-for-us-frontier-labs.md +++ b/domains/ai-alignment/eu-gpai-requirements-create-extraterritorial-governance-asymmetry-for-us-frontier-labs.md @@ -19,8 +19,10 @@ related: - eu-ai-act-military-exclusion-gap-limits-governance-scope-to-civilian-systems supports: - EU AI Act GPAI evaluation requirements represent the only surviving mandatory governance mechanism targeting frontier AI after the omnibus deferral because systemic-risk model providers face mandatory evaluation risk assessment and AI Office notification from August 2026 while high-risk deployment requirements were deferred 16-24 months +- EU GPAI compliance is commercially driven by market access leverage rather than enforcement threat producing minimum-viable documentation compliance reweave_edges: - EU AI Act GPAI evaluation requirements represent the only surviving mandatory governance mechanism targeting frontier AI after the omnibus deferral because systemic-risk model providers face mandatory evaluation risk assessment and AI Office notification from August 2026 while high-risk deployment requirements were deferred 16-24 months|supports|2026-05-10 +- EU GPAI compliance is commercially driven by market access leverage rather than enforcement threat producing minimum-viable documentation compliance|supports|2026-05-11 --- # EU GPAI requirements apply to US frontier AI labs without equivalent domestic US requirements creating a de facto extraterritorial governance asymmetry where AI producers face mandatory EU evaluation that US law does not impose diff --git a/domains/ai-alignment/multilateral-verification-mechanisms-can-substitute-for-failed-voluntary-commitments-when-binding-enforcement-replaces-unilateral-sacrifice.md b/domains/ai-alignment/multilateral-verification-mechanisms-can-substitute-for-failed-voluntary-commitments-when-binding-enforcement-replaces-unilateral-sacrifice.md index 1740c20fa..0fa2bbb16 100644 --- a/domains/ai-alignment/multilateral-verification-mechanisms-can-substitute-for-failed-voluntary-commitments-when-binding-enforcement-replaces-unilateral-sacrifice.md +++ b/domains/ai-alignment/multilateral-verification-mechanisms-can-substitute-for-failed-voluntary-commitments-when-binding-enforcement-replaces-unilateral-sacrifice.md @@ -14,10 +14,12 @@ attribution: related: - EU AI Act extraterritorial enforcement can create binding governance constraints on US AI labs through market access requirements when domestic voluntary commitments fail - Mutually Assured Deregulation makes voluntary AI governance structurally untenable because each actor's restraint creates competitive disadvantage, converting the governance game from cooperation to prisoner's dilemma +- AI verification limits are invoked as corporate safety arguments in government contract disputes rather than just technical research findings reweave_edges: - EU AI Act extraterritorial enforcement can create binding governance constraints on US AI labs through market access requirements when domestic voluntary commitments fail|related|2026-04-06 - Voluntary safety constraints without external enforcement mechanisms are statements of intent not binding governance because aspirational language with loopholes enables compliance theater while preserving operational flexibility|supports|2026-04-07 - Mutually Assured Deregulation makes voluntary AI governance structurally untenable because each actor's restraint creates competitive disadvantage, converting the governance game from cooperation to prisoner's dilemma|related|2026-04-25 +- AI verification limits are invoked as corporate safety arguments in government contract disputes rather than just technical research findings|related|2026-05-11 supports: - Voluntary safety constraints without external enforcement mechanisms are statements of intent not binding governance because aspirational language with loopholes enables compliance theater while preserving operational flexibility --- diff --git a/domains/entertainment/ai-filmmaking-community-develops-institutional-validation-structures-rather-than-replacing-community-with-algorithmic-reach.md b/domains/entertainment/ai-filmmaking-community-develops-institutional-validation-structures-rather-than-replacing-community-with-algorithmic-reach.md index e48ed98eb..846cab652 100644 --- a/domains/entertainment/ai-filmmaking-community-develops-institutional-validation-structures-rather-than-replacing-community-with-algorithmic-reach.md +++ b/domains/entertainment/ai-filmmaking-community-develops-institutional-validation-structures-rather-than-replacing-community-with-algorithmic-reach.md @@ -99,7 +99,8 @@ AIF 2026 expands beyond film into New Media, Gaming, Design, Advertising, Fashio **Source:** Runway AIF 2026 category expansion + Hundred Film Fund status as of April 2026 AIF 2026 expanded beyond film into New Media, Gaming, Design, Advertising, and Fashion categories, with screenings at Alice Tully Hall (NYC) and The Broad Stage (LA). This expansion into non-film categories while the Hundred Film Fund has not publicly disclosed any funded or completed films after 18 months suggests institutional scaffolding is being built faster than demonstration-quality AI narrative films are being produced. The festival functions as marketing vehicle while actual funded filmmaking remains slower. - +supports: +- AI film festival ecosystem institutionalizing in 2026 provides cultural validation infrastructure for the disruptive path analogous to Sundance for indie film in the 1990s --- # AI filmmaking is developing institutional community validation structures rather than replacing community with algorithmic reach diff --git a/domains/grand-strategy/voluntary-ai-safety-constraints-lack-legal-enforcement-mechanism-when-primary-customer-demands-safety-unconstrained-alternatives.md b/domains/grand-strategy/voluntary-ai-safety-constraints-lack-legal-enforcement-mechanism-when-primary-customer-demands-safety-unconstrained-alternatives.md index b9a11eef6..cb714473c 100644 --- a/domains/grand-strategy/voluntary-ai-safety-constraints-lack-legal-enforcement-mechanism-when-primary-customer-demands-safety-unconstrained-alternatives.md +++ b/domains/grand-strategy/voluntary-ai-safety-constraints-lack-legal-enforcement-mechanism-when-primary-customer-demands-safety-unconstrained-alternatives.md @@ -16,6 +16,7 @@ reweave_edges: - Voluntary safety constraints without external enforcement mechanisms are statements of intent not binding governance because aspirational language with loopholes enables compliance theater while preserving operational flexibility|supports|2026-04-07 - Legible immediate harm enforces governance convergence independent of competitive incentives because OpenAI implemented access restrictions on GPT-5.5 Cyber identical to Anthropic's Mythos restrictions within weeks of publicly criticizing Anthropic's approach|related|2026-05-05 - Pentagon exclusion creates EU civilian compliance advantage through pre-aligned safety practices when enforcement proceeds|related|2026-05-05 +- Hard safety constraints backed by litigation survive government coercion where soft voluntary pledges collapse under competitive pressure|related|2026-05-11 related: - voluntary-ai-safety-constraints-lack-legal-enforcement-mechanism-when-primary-customer-demands-safety-unconstrained-alternatives - judicial-oversight-of-ai-governance-through-constitutional-grounds-not-statutory-safety-law @@ -27,6 +28,7 @@ related: - independent-ai-evaluation-infrastructure-faces-evaluation-enforcement-disconnect - Legible immediate harm enforces governance convergence independent of competitive incentives because OpenAI implemented access restrictions on GPT-5.5 Cyber identical to Anthropic's Mythos restrictions within weeks of publicly criticizing Anthropic's approach - Pentagon exclusion creates EU civilian compliance advantage through pre-aligned safety practices when enforcement proceeds +- Hard safety constraints backed by litigation survive government coercion where soft voluntary pledges collapse under competitive pressure --- # Voluntary AI safety constraints are protected as corporate speech but unenforceable as safety requirements, creating legal mechanism gap when primary demand-side actor seeks safety-unconstrained providers diff --git a/domains/health/ibogaine-federal-policy-priority-rests-on-single-n30-pilot-illustrating-veteran-constituency-acceleration-ahead-of-evidence-hierarchy.md b/domains/health/ibogaine-federal-policy-priority-rests-on-single-n30-pilot-illustrating-veteran-constituency-acceleration-ahead-of-evidence-hierarchy.md index f3a9f34b0..a6d2023ae 100644 --- a/domains/health/ibogaine-federal-policy-priority-rests-on-single-n30-pilot-illustrating-veteran-constituency-acceleration-ahead-of-evidence-hierarchy.md +++ b/domains/health/ibogaine-federal-policy-priority-rests-on-single-n30-pilot-illustrating-veteran-constituency-acceleration-ahead-of-evidence-hierarchy.md @@ -11,6 +11,10 @@ sourced_from: health/2024-xx-stanford-ibogaine-veterans-ptsd-n30.md scope: structural sourcer: Stanford University School of Medicine / CNN / NPR related: ["healthcare-ai-regulation-needs-blank-sheet-redesign", "the mental health supply gap is widening not closing because demand outpaces workforce growth and technology primarily serves the already-served rather than expanding access"] +supports: +- Stanford Ibogaine Veterans Study +reweave_edges: +- Stanford Ibogaine Veterans Study|supports|2026-05-11 --- # Ibogaine's federal policy priority in 2026 rests on a single n=30 pilot study illustrating how veteran political constituencies can accelerate regulatory posture ahead of evidence hierarchies diff --git a/domains/health/ibogaine-iv-magnesium-protocol-demonstrates-cardiac-risk-manageable-in-supervised-settings-addressing-primary-safety-barrier.md b/domains/health/ibogaine-iv-magnesium-protocol-demonstrates-cardiac-risk-manageable-in-supervised-settings-addressing-primary-safety-barrier.md index 882ed903b..9b1a540ac 100644 --- a/domains/health/ibogaine-iv-magnesium-protocol-demonstrates-cardiac-risk-manageable-in-supervised-settings-addressing-primary-safety-barrier.md +++ b/domains/health/ibogaine-iv-magnesium-protocol-demonstrates-cardiac-risk-manageable-in-supervised-settings-addressing-primary-safety-barrier.md @@ -11,6 +11,12 @@ sourced_from: health/2024-xx-stanford-ibogaine-veterans-ptsd-n30.md scope: functional sourcer: Stanford University School of Medicine related: ["healthcare-ai-regulation-needs-blank-sheet-redesign"] +supports: +- Ibogaine's federal policy priority in 2026 rests on a single n=30 pilot study illustrating how veteran political constituencies can accelerate regulatory posture ahead of evidence hierarchies +- Stanford Ibogaine Veterans Study +reweave_edges: +- Ibogaine's federal policy priority in 2026 rests on a single n=30 pilot study illustrating how veteran political constituencies can accelerate regulatory posture ahead of evidence hierarchies|supports|2026-05-11 +- Stanford Ibogaine Veterans Study|supports|2026-05-11 --- # IV magnesium protocol demonstrates ibogaine's cardiac risk is manageable in supervised clinical settings addressing the primary safety barrier to Phase 3 trials diff --git a/domains/health/mdma-assisted-therapy-functional-unblinding-invalidates-self-reported-outcomes-despite-phase3-efficacy.md b/domains/health/mdma-assisted-therapy-functional-unblinding-invalidates-self-reported-outcomes-despite-phase3-efficacy.md index 170e76be5..cc3bad5e3 100644 --- a/domains/health/mdma-assisted-therapy-functional-unblinding-invalidates-self-reported-outcomes-despite-phase3-efficacy.md +++ b/domains/health/mdma-assisted-therapy-functional-unblinding-invalidates-self-reported-outcomes-despite-phase3-efficacy.md @@ -11,6 +11,10 @@ sourced_from: health/2024-08-09-fda-mdma-ptsd-complete-response-letter-lykos.md scope: structural sourcer: FDA / Psychiatric Times / STAT News related: ["prescription-digital-therapeutics-failed-as-a-business-model-because-fda-clearance-creates-regulatory-cost-without-the-pricing-power-that-justifies-it-for-near-zero-marginal-cost-software"] +supports: +- Psychedelic therapy regulatory approval requires either active comparator designs or objective endpoints because highly psychoactive compounds create functional unblinding that invalidates self-reported psychiatric outcomes +reweave_edges: +- Psychedelic therapy regulatory approval requires either active comparator designs or objective endpoints because highly psychoactive compounds create functional unblinding that invalidates self-reported psychiatric outcomes|supports|2026-05-11 --- # MDMA-assisted therapy's FDA rejection reveals that clinical efficacy is necessary but insufficient for regulatory approval when functional unblinding invalidates self-reported outcomes in psychiatry trials diff --git a/domains/health/psilocybin-achieves-positive-phase3-trd-single-dose-26week-durability.md b/domains/health/psilocybin-achieves-positive-phase3-trd-single-dose-26week-durability.md index 9f24a2253..e07b8f681 100644 --- a/domains/health/psilocybin-achieves-positive-phase3-trd-single-dose-26week-durability.md +++ b/domains/health/psilocybin-achieves-positive-phase3-trd-single-dose-26week-durability.md @@ -12,6 +12,10 @@ scope: causal sourcer: Compass Pathways challenges: ["prescription-digital-therapeutics-failed-as-a-business-model-because-fda-clearance-creates-regulatory-cost-without-the-pricing-power-that-justifies-it-for-near-zero-marginal-cost-software"] related: ["the-mental-health-supply-gap-is-widening-not-closing-because-demand-outpaces-workforce-growth-and-technology-primarily-serves-the-already-served-rather-than-expanding-access", "prescription-digital-therapeutics-failed-as-a-business-model-because-fda-clearance-creates-regulatory-cost-without-the-pricing-power-that-justifies-it-for-near-zero-marginal-cost-software", "antidepressant-discontinuation-follows-continuous-treatment-model-but-psychological-support-mitigates-relapse"] +supports: +- Trump's April 2026 Executive Order on psychedelics represents the first federal bipartisan commitment to Schedule I psychedelic drug development pathways, signaling regulatory environment shift that de-risks clinical investment through existing frameworks rather than new legislation +reweave_edges: +- Trump's April 2026 Executive Order on psychedelics represents the first federal bipartisan commitment to Schedule I psychedelic drug development pathways, signaling regulatory environment shift that de-risks clinical investment through existing frameworks rather than new legislation|supports|2026-05-11 --- # Psilocybin achieves positive Phase 3 evidence for treatment-resistant depression with single-dose 26-week durability representing the first FDA-approvable psychedelic diff --git a/domains/health/psychedelic-therapy-regulatory-success-requires-active-comparator-or-objective-endpoints-for-highly-psychoactive-compounds.md b/domains/health/psychedelic-therapy-regulatory-success-requires-active-comparator-or-objective-endpoints-for-highly-psychoactive-compounds.md index a7b03684b..aa8eecb17 100644 --- a/domains/health/psychedelic-therapy-regulatory-success-requires-active-comparator-or-objective-endpoints-for-highly-psychoactive-compounds.md +++ b/domains/health/psychedelic-therapy-regulatory-success-requires-active-comparator-or-objective-endpoints-for-highly-psychoactive-compounds.md @@ -10,6 +10,15 @@ agent: vida sourced_from: health/2024-08-09-fda-mdma-ptsd-complete-response-letter-lykos.md scope: structural sourcer: FDA / Psychiatric Times / STAT News +supports: +- MDMA-assisted therapy's FDA rejection reveals that clinical efficacy is necessary but insufficient for regulatory approval when functional unblinding invalidates self-reported outcomes in psychiatry trials +reweave_edges: +- MDMA-assisted therapy's FDA rejection reveals that clinical efficacy is necessary but insufficient for regulatory approval when functional unblinding invalidates self-reported outcomes in psychiatry trials|supports|2026-05-11 +- Psilocybin achieves positive Phase 3 evidence for treatment-resistant depression with single-dose 26-week durability representing the first FDA-approvable psychedelic|related|2026-05-11 +- Psilocybin therapy requires psychological support as an embedded clinical protocol component not an optional adjunct|related|2026-05-11 +related: +- Psilocybin achieves positive Phase 3 evidence for treatment-resistant depression with single-dose 26-week durability representing the first FDA-approvable psychedelic +- Psilocybin therapy requires psychological support as an embedded clinical protocol component not an optional adjunct --- # Psychedelic therapy regulatory approval requires either active comparator designs or objective endpoints because highly psychoactive compounds create functional unblinding that invalidates self-reported psychiatric outcomes diff --git a/domains/health/trump-2026-psychedelic-executive-order-creates-bipartisan-regulatory-acceleration-through-existing-frameworks.md b/domains/health/trump-2026-psychedelic-executive-order-creates-bipartisan-regulatory-acceleration-through-existing-frameworks.md index e59ddf589..d9ea7802a 100644 --- a/domains/health/trump-2026-psychedelic-executive-order-creates-bipartisan-regulatory-acceleration-through-existing-frameworks.md +++ b/domains/health/trump-2026-psychedelic-executive-order-creates-bipartisan-regulatory-acceleration-through-existing-frameworks.md @@ -12,6 +12,10 @@ scope: structural sourcer: White House / FDA challenges: ["healthcare-ai-regulation-needs-blank-sheet-redesign"] related: ["healthcare-ai-regulation-needs-blank-sheet-redesign", "fda-2026-cds-enforcement-discretion-expands-to-single-recommendation-ai-without-defining-clinical-appropriateness"] +supports: +- Ibogaine's federal policy priority in 2026 rests on a single n=30 pilot study illustrating how veteran political constituencies can accelerate regulatory posture ahead of evidence hierarchies +reweave_edges: +- Ibogaine's federal policy priority in 2026 rests on a single n=30 pilot study illustrating how veteran political constituencies can accelerate regulatory posture ahead of evidence hierarchies|supports|2026-05-11 --- # Trump's April 2026 Executive Order on psychedelics represents the first federal bipartisan commitment to Schedule I psychedelic drug development pathways, signaling regulatory environment shift that de-risks clinical investment through existing frameworks rather than new legislation diff --git a/domains/internet-finance/genius-act-public-company-restriction-creates-asymmetric-big-tech-barrier-while-permitting-private-non-financial-issuers.md b/domains/internet-finance/genius-act-public-company-restriction-creates-asymmetric-big-tech-barrier-while-permitting-private-non-financial-issuers.md index 8ff02317f..d0b6b0c11 100644 --- a/domains/internet-finance/genius-act-public-company-restriction-creates-asymmetric-big-tech-barrier-while-permitting-private-non-financial-issuers.md +++ b/domains/internet-finance/genius-act-public-company-restriction-creates-asymmetric-big-tech-barrier-while-permitting-private-non-financial-issuers.md @@ -12,9 +12,11 @@ sourcer: Nellie Liang, Brookings Institution related: - GENIUS Act freeze/seize requirement creates mandatory control surface that conflicts with autonomous smart contract payment coordination - GENIUS Act reserve custody rules create indirect banking system dependency for nonbank stablecoin issuers without requiring bank charter +- GENIUS Act stablecoin yield prohibition reveals rent-protection motive because White House economists find negligible lending protection ($2.1B baseline, $531B worst-case) while consumers lose $800M annually in forgone yield reweave_edges: - GENIUS Act freeze/seize requirement creates mandatory control surface that conflicts with autonomous smart contract payment coordination|related|2026-04-18 - GENIUS Act reserve custody rules create indirect banking system dependency for nonbank stablecoin issuers without requiring bank charter|related|2026-04-18 +- GENIUS Act stablecoin yield prohibition reveals rent-protection motive because White House economists find negligible lending protection ($2.1B baseline, $531B worst-case) while consumers lose $800M annually in forgone yield|related|2026-05-11 --- # GENIUS Act public company restriction creates asymmetric Big Tech barrier while permitting private non-financial issuers diff --git a/domains/internet-finance/genius-act-reserve-custody-creates-indirect-banking-dependency-for-nonbank-stablecoin-issuers.md b/domains/internet-finance/genius-act-reserve-custody-creates-indirect-banking-dependency-for-nonbank-stablecoin-issuers.md index a221ffde9..8797ec965 100644 --- a/domains/internet-finance/genius-act-reserve-custody-creates-indirect-banking-dependency-for-nonbank-stablecoin-issuers.md +++ b/domains/internet-finance/genius-act-reserve-custody-creates-indirect-banking-dependency-for-nonbank-stablecoin-issuers.md @@ -15,10 +15,12 @@ supports: related: - GENIUS Act freeze/seize requirement creates mandatory control surface that conflicts with autonomous smart contract payment coordination - genius-act-public-company-restriction-creates-asymmetric-big-tech-barrier-while-permitting-private-non-financial-issuers +- GENIUS Act stablecoin yield prohibition reveals rent-protection motive because White House economists find negligible lending protection ($2.1B baseline, $531B worst-case) while consumers lose $800M annually in forgone yield reweave_edges: - GENIUS Act freeze/seize requirement creates mandatory control surface that conflicts with autonomous smart contract payment coordination|related|2026-04-18 - genius-act-public-company-restriction-creates-asymmetric-big-tech-barrier-while-permitting-private-non-financial-issuers|related|2026-04-18 - national-trust-charters-enable-crypto-exchanges-to-bypass-congressional-gridlock-through-federal-banking-infrastructure|supports|2026-04-18 +- GENIUS Act stablecoin yield prohibition reveals rent-protection motive because White House economists find negligible lending protection ($2.1B baseline, $531B worst-case) while consumers lose $800M annually in forgone yield|related|2026-05-11 --- # GENIUS Act reserve custody rules create indirect banking system dependency for nonbank stablecoin issuers without requiring bank charter diff --git a/domains/space-development/amazon-kuiper-selective-governance-participation-reveals-strategic-preference-for-flexible-principles-over-mandatory-operational-rules.md b/domains/space-development/amazon-kuiper-selective-governance-participation-reveals-strategic-preference-for-flexible-principles-over-mandatory-operational-rules.md index f94daff52..f77fd23ba 100644 --- a/domains/space-development/amazon-kuiper-selective-governance-participation-reveals-strategic-preference-for-flexible-principles-over-mandatory-operational-rules.md +++ b/domains/space-development/amazon-kuiper-selective-governance-participation-reveals-strategic-preference-for-flexible-principles-over-mandatory-operational-rules.md @@ -11,6 +11,10 @@ sourced_from: space-development/2026-05-10-spacenews-amazon-kuiper-wef-guideline scope: functional sourcer: LightReading / About Amazon related: ["spacex-refusal-to-endorse-wef-debris-governance-instantiates-voluntary-governance-failure-in-orbital-commons", "fcc-orbital-debris-governance-applies-competitive-market-logic-to-commons-externality-problem"] +supports: +- SpaceX and Amazon Kuiper non-endorsement of WEF debris guidelines demonstrates systemic voluntary governance failure at the scale where it matters most +reweave_edges: +- SpaceX and Amazon Kuiper non-endorsement of WEF debris guidelines demonstrates systemic voluntary governance failure at the scale where it matters most|supports|2026-05-11 --- # Amazon Kuiper selective governance participation reveals strategic preference for flexible principles-based frameworks over mandatory operational rules diff --git a/entities/health/stanford-ibogaine-veterans-study.md b/entities/health/stanford-ibogaine-veterans-study.md index 2577f33d8..34cabb49e 100644 --- a/entities/health/stanford-ibogaine-veterans-study.md +++ b/entities/health/stanford-ibogaine-veterans-study.md @@ -4,6 +4,12 @@ entity_type: research_program name: Stanford Ibogaine Veterans Study domain: health status: completed +supports: +- Ibogaine's federal policy priority in 2026 rests on a single n=30 pilot study illustrating how veteran political constituencies can accelerate regulatory posture ahead of evidence hierarchies +- IV magnesium protocol demonstrates ibogaine's cardiac risk is manageable in supervised clinical settings addressing the primary safety barrier to Phase 3 trials +reweave_edges: +- Ibogaine's federal policy priority in 2026 rests on a single n=30 pilot study illustrating how veteran political constituencies can accelerate regulatory posture ahead of evidence hierarchies|supports|2026-05-11 +- IV magnesium protocol demonstrates ibogaine's cardiac risk is manageable in supervised clinical settings addressing the primary safety barrier to Phase 3 trials|supports|2026-05-11 --- # Stanford Ibogaine Veterans Study diff --git a/entities/internet-finance/genius-act.md b/entities/internet-finance/genius-act.md index 2a5df2359..9a3c8bf3c 100644 --- a/entities/internet-finance/genius-act.md +++ b/entities/internet-finance/genius-act.md @@ -21,10 +21,12 @@ related: - GENIUS Act freeze/seize requirement creates mandatory control surface that conflicts with autonomous smart contract payment coordination - genius-act-public-company-restriction-creates-asymmetric-big-tech-barrier-while-permitting-private-non-financial-issuers - GENIUS Act reserve custody rules create indirect banking system dependency for nonbank stablecoin issuers without requiring bank charter +- GENIUS Act stablecoin yield prohibition reveals rent-protection motive because White House economists find negligible lending protection ($2.1B baseline, $531B worst-case) while consumers lose $800M annually in forgone yield reweave_edges: - GENIUS Act freeze/seize requirement creates mandatory control surface that conflicts with autonomous smart contract payment coordination|related|2026-04-18 - genius-act-public-company-restriction-creates-asymmetric-big-tech-barrier-while-permitting-private-non-financial-issuers|related|2026-04-18 - GENIUS Act reserve custody rules create indirect banking system dependency for nonbank stablecoin issuers without requiring bank charter|related|2026-04-18 +- GENIUS Act stablecoin yield prohibition reveals rent-protection motive because White House economists find negligible lending protection ($2.1B baseline, $531B worst-case) while consumers lose $800M annually in forgone yield|related|2026-05-11 --- # GENIUS Act (Guiding and Establishing National Innovation for U.S. Stablecoins of 2025)